| Literature DB >> 32473036 |
Qing Huang1, Guanyi Liu2, Jiewei Wang3, Tianjiao Duan4, Yun Feng5, Xiaoqing Lin6, Yuanmin Zhu7, Huihui Wang7, Yi Cui6, Shuixiang He5, Yunqing Zhu4, Peng Li3, Long Rong2, Yulan Liu1.
Abstract
AIMS: To investigate control measures for COVID-19 pandemic in GIE centers in China.Entities:
Keywords: Coronavirus disease 2019; control measure; endoscopy; hospital infection
Mesh:
Year: 2020 PMID: 32473036 PMCID: PMC7300959 DOI: 10.1111/den.13755
Source DB: PubMed Journal: Dig Endosc ISSN: 0915-5635 Impact factor: 6.337
General features and staff status
| Center 1 | Center 2 | Center 3 | Center 4 | Center 5 | Center 6 | Center 7 | |
|---|---|---|---|---|---|---|---|
| Number of COVID‐19 definite cases in hospital | 4 | 1 | 0 | 0 | 2 | 16 | 5 |
| Number of operating tables | 5 | 3 | 5 | 10 | 16 | 6 | 10 |
| Number of endoscopists | 17 | 12 | 29 | 13 | 51 | 22 | 15 |
| Number of nurse assistants | 9 | 7 | 15 | 19 | 21 | 6 | 15 |
| Shutdown date, mm‐dd | 02‐01 | 02‐01 | 02‐01 | 02‐01 | NA | 02‐01 | 02‐01 |
| Return to work date, mm‐dd | 03‐30 | 03‐02 | 03‐23 | 03‐23 | NA | 03‐02 | 02‐24 |
| Shutdown days (weekends excluded) | 40 | 20 | 35 | 35 | 0 | 20 | 15 |
| Working time of an endoscopist per month, days | |||||||
| Return to work period | 2 | 10 | 20 | 5 | 10 | 20 | 12 |
| The same period last year | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
| Number of endoscopists on duty per day | |||||||
| Return to work period | 1 | 3 | 5 | 5 | 7 | 5 | 6 |
| The same period last year | 8 | 6 | 7 | 13 | 18 | 10 | 8 |
| Number of endoscopic learners per month at the same period last year | 8 | 3 | 4 | 5 | 45 | 7 | 20 |
NA, not applicable. The definition of shutdown date was the date suspending routine appointment GIE procedures. The definition of return to work date was the date resuming routine appointment GIE procedures.
COVID‐19 screening strategies
| Subjects | Number of GIE centers | |||
|---|---|---|---|---|
| Patient | Family member | |||
| Shutdown | Return to work | Shutdown | Return to work | |
| COVID‐19 screening | ||||
| Yes | 6 (100%) | 7 (100%) | 5 (83%) | 6 (86%) |
| Epidemiological questionnaire | 6 (100%) | 7 (100%) | 5 (83%) | 6 (86%) |
| Temperature taking | 6 (100%) | 7 (100%) | 5 (83%) | 6 (86%) |
| QR‐code of journey | 6 (100%) | 7 (100%) | 5 (83%) | 6 (86%) |
| Antibody test of SARS‐CoV‐2 | 3 (50%) | 1 (14%) | 1 (17%) | 0 |
| Nucleic acid test of SARS‐CoV‐2 | 2 (33%) | 1 (14%) | 1 (17%) | 0 |
| Chest CT scan | 6 (100%) | 5 (71%) | 3 (50%) | 0 |
| BR, CRP | 1 (17%) | 1 (14%) | 1 (17%) | 0 |
Application of PPE in GIE centers
| Subjects | Number of GIE centers | ||
|---|---|---|---|
| Shutdown | Return to work | The same period last year | |
| Disposable medical mask | 0 | 0 | 3 (43%) |
| Disposable surgical mask | 5 (83%) | 6 (86%) | 4 (57%) |
| N95 mask | 1 (17%) | 2 (29%) | 0 |
| Latex gloves (one pair) | 2 (33%) | 3 (43%) | 6 (86%) |
| Latex gloves (two pairs) | 4 (67%) | 4 (57%) | 1 (14%) |
| Disposable cap | 6 (100%) | 7 (100%) | 6 (86%) |
| Non‐disposable cap | 0 | 0 | 1 (14%) |
| Goggles | 6 (100%) | 6 (86%) | 0 |
| Face shield | 5 (83%) | 6 (86%) | 0 |
| Shoe cover | 6 (100%) | 7 (100%) | 3 (43%) |
| Disposable isolation gown | 3 (50%) | 4 (57%) | 0 |
| Non‐disposable isolation gown | 2 (33%) | 3 (43%) | 7 (100%) |
| Protective suit | 2 (33%) | 2 (29%) | 0 |
Sterilizing measures of GIE centers
| Period/disinfection frequency | Operation room | Endoscope | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Center 1 | Center 2 | Center 3 | Center 4 | Center 5 | Center 6 | Center 7 | Center 1 | Center 2 | Center 3 | Center 4 | Center 5 | Center 6 | Center 7 | |
| Shutdown |
① ②(30 min) ③ |
① ②(30 min) ③ |
②(60 min) |
① ②(60 min) ③ | NA |
① ②(60 min) ③ |
① ③ | ⑤(10 min) |
⑦(wash) ⑥(10 h) | ⑧(20 min) | ⑤(5 min) | NA |
⑧(5 min) ⑤(10 min) | ⑤(10 min) |
| Frequency | 1/P |
①②2/D; ③persistently | 2/D | 1/P | NA |
①②1/P; ③persistently | 2/D | 1/P | 1/P | 1/P | 1/P | NA | 1/P | 1/P |
| Return to work |
① ②(30 min) ③ |
① ②(30 min) ③ |
① ④ |
① ②(60 min) ③ |
① ②(60 min) ③ |
① ②(60 min) ③ |
① ③ | ⑤(10 min) | ⑦(3 min) | ⑤+⑧(20 min) | ⑤+⑦+⑧(5 min) |
⑦(5 min) ⑤(15 min) ⑦(5 min) |
⑧(5 min) ⑤(10 min) | ⑤(10 min) |
| Frequency | 1/P |
①②2/D; ③persistently |
①2/D; ④1/D | 2/D |
①1/P ②③3/D |
①②1/P; ③persistently | 2/D | 1/P | 1/P | 1/P | 1/P | 1/P | 1/P | 1/P |
| The same period last year |
① ③ |
① ③ |
① ④ |
① ③ |
① ②(60 min) ③ |
① ③ |
① ③ |
⑥(10 min) ⑦(3 min) | ⑦(3 min) | ⑤+⑧(20 min) | ⑤+⑦+⑧(5 min) |
⑤(15 min) ⑦(5 min) | ⑧(5 min) | ⑤(10 min) |
| Frequency | 2/D | 2/D |
①2/D; ④1/D | 2/D | 1/D |
①2/D; ③persistently | 2/D | 1/P | 1/P | 1/P | 1/P | 1/P | 1/P | 1/P |
NA, not applicable; ① Wipe instruments’ surface and floor (500 mg/L CRAS); ② ultraviolet; ③ natural ventilation; ④ electronic air cleaner; ⑤ 0.3% peracetic acid; ⑥ glutaraldehyde; ⑦ acidified water; ⑧ OPA. 1/P: once per person; 1/D: once a day; 2/D: twice a day; 3/D: three times a day. The sequences listed in the table were the execution steps.